SEPN Competitors & Alternatives
Compare Septerna, Inc. Common Stock with similar stocks in the same industry
Biotechnology
SEPN
Main Stock$23.04
Tradestie Score
55
Market Cap
$847.12M
Revenue Growth
112.8%
Analyst Upside
+92.8%
Top Competitors
222 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
PGEN
Precigen, Inc. Common Stock
|
$4.07
|
$1.18B | - | 55 | Compare |
|
ELVN
Enliven Therapeutics, Inc. Common Stock
|
$42.14
|
$1.17B | - | 58 | Compare |
|
INVA
Innoviva, Inc. Common Stock
|
$23.09
|
$1.15B | 7.1 | 59 | Compare |
|
TRVI
Trevi Therapeutics, Inc. Common Stock
|
$13.90
|
$1.14B | - | 55 | Compare |
|
ORIC
Oric Pharmaceuticals, Inc. Common Stock
|
$9.39
|
$1.14B | - | 60 | Compare |
|
MAZE
Maze Therapeutics, Inc. Common Stock
|
$25.58
|
$1.13B | - | 55 | Compare |
|
WVE
Wave Life Sciences Ltd. Ordinary Shares
|
$7.04
|
$1.12B | - | 57 | Compare |
|
NKTR
Nektar Therapeutics
|
$82.64
|
$1.12B | - | 58 | Compare |
|
PRAX
Praxis Precision Medicines, Inc. Common Stock
|
$318.79
|
$1.12B | - | 58 | Compare |
|
IMTX
Immatics N.V. Ordinary Shares
|
$11.14
|
$1.09B | - | 62 | Compare |
More SEPN Analysis
Data updated: Apr 29, 2026 | Industry: Biotechnology (SIC 2834)
222 stocks in this industry